SCHEMBL16199839

SCHEMBL16199839

B=C(COc1ccc2ncnc(Nc3ccc(F)c(C)c3)c2c1)Nc1cc(-c2cccs2)ccc1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 12/20 0.54
▸ EGFR P00533 4/20 0.46
▸ RIPK2 O43353 1/20 0.45
▸ RIPK3 Q9Y572 1/20 0.45
▸ AURKB Q96GD4 2/20 0.42
▸ CD38 P28907 3/20 0.41
▸ HDAC3 O15379 10/20 0.41
▸ HDAC2 Q92769 10/20 0.41
▸ HDAC4 P56524 6/20 0.41
▸ HDAC7 Q8WUI4 6/20 0.41
▸ HDAC10 Q969S8 6/20 0.41
▸ HDAC11 Q96DB2 6/20 0.41
▸ HDAC8 Q9BY41 6/20 0.41
▸ HDAC6 Q9UBN7 6/20 0.41
▸ HDAC9 Q9UKV0 6/20 0.41
▸ HDAC5 Q9UQL6 6/20 0.41
▸ ABL1 P00519 3/20 0.40
▸ ERBB2 P04626 3/20 0.40
▸ PDGFRB P09619 3/20 0.40
▸ CDK2 P24941 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16199840 0.92 HDAC1 (0.50) HDAC1EGFRRIPK2RIPK3AURKB
SCHEMBL10118518 0.83 EGFR (0.69) HDAC1EGFRAURKBCD38HDAC3
SCHEMBL8212591 0.80 EGFR (0.46) HDAC1EGFRHDAC3HDAC2HDAC4
SCHEMBL10118519 0.78 EGFR (0.64) HDAC1EGFRCD38HDAC3HDAC2
SCHEMBL8212590 0.78 EGFR (0.52) HDAC1EGFRHDAC3HDAC2HDAC4
SCHEMBL8209641 0.77 EGFR (0.49) HDAC1EGFRHDAC3HDAC2HDAC4
SCHEMBL16199858 0.77 EGFR (0.57) HDAC1EGFRRIPK2RIPK3HDAC3
SCHEMBL8213795 0.77 EGFR (0.66) HDAC1EGFRHDAC3HDAC2HDAC4
SCHEMBL13928029 0.77 EGFR (0.73) HDAC1EGFRHDAC3HDAC2HDAC4
SCHEMBL8215061 0.76 EGFR (0.63) HDAC1EGFRHDAC3HDAC2HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2190287-B1 TARTRATE SALTS OR COMPLEXES OF QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY CURIS INC (US) 2014-10-29 — — EP disclosed
Send feedback